High-intensity Laser Therapy Versus Extracorporeal Shock Wave on Tendon Thickness and Occupation Ratio In Patients With Chronic Supraspinatus Tendinopathy (HILT)
19 de junio de 2026 actualizado por: Mahmoud Mamdouh Ahmed Shaaban, Cairo University
This study will be conducted to investigate the difference between high-intensity laser and extracorporeal shock wave on supraspinatus tendon thickness, subacromial space, occupation ratio, shoulder pain intensity, shoulder range of motion (ROM), hand strength, and functional disability in patients with chronic supraspinatus tendinopathy.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Descripción detallada
Supraspinatus tendinopathy is a common cause of shoulder pain and dysfunction due to irritation, inflammation, or degeneration of the supraspinatus tendon in the rotator cuff.
It is caused by repetitive overhead movements and is characterized by pain, weakness, and a limited range of motion, especially when reaching or lifting the arm.
Recently, studies have demonstrated that HILT is useful for treating a variety of shoulder impairments, including subacromial impingement syndrome, rotator cuff tendinopathy, and adhesive capsulitis.Shock wave is an effective and noninvasive method of reducing pain and increasing ROM and functional status without the need for surgery; it has been successfully utilized to treat tendinopathy over the past 20 years.There is a gap in available literature about comparing the high-intensity laser and extracorporeal shock wave in patients withchronic supraspinatus tendonitis.
So this study may add a piece of information to the physiotherapists in the government hospitals and the private clinics about showing the difference between the application of High Intensity laser and extracorporeal shock wave in patients with chronic supraspinatus tendinitis
Tipo de estudio
Intervencionista
Inscripción (Estimado)
69
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: mahmoud shaaban, phd
- Número de teléfono: 01001080842
- Correo electrónico: shaabab.m@outlook.com
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Patients from 18 to 50 years old of both genders.
- Unilateral Chronic Supraspinatus Tendinitis in dominant side
- BMI 18.5-24.9
- Tenderness is found over the supraspinatus as it passes subacromial and anterolateral The patient will report pain with active shoulder elevation in the scapular plane (eg: welders, plate workers, slaughterhouse workers and overhead playing athletes)
- The patient will report pain with resisted isometric abduction.
- The patient will report positive Jobe's test (empty can test)
Exclusion Criteria:
- Post shoulder surgery, traumatic incidents
- Partial tears at surgery
- Massive retracted tears at surgery
- Frozen shoulder Rotator cuff tear
- Glenohumeral or acromioclavicular arthritis
- Implanted pacemaker
- Pregnancy
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: High-intensity Laser Therapy
Twenty-three patients with chronic supraspinatus tendinopathy will receive high-intensity laser and conventional physiotherapy twice a week for six weeks
|
the patients will receive HILT with peak power 3kW, intensity 15000W/cm and energy per pulse 350 mj) at supraspinatus tendenopathy.The treatment consisted of 3 phases in each session.
the initial phase will be rapid manual scanning (100 cm2/30s) of the anterior joint line of the shoulder with one shot of 850 mj at frequency of 30 Hz.
The scanning will be performed parallel to the joint line, with the patient arm internally rotated on the posterior scan and externally rotated on the anterior scan.
the intermediate phase will be a fixed scan phase , with one -shot emission of 350mj at a frequency of 20-25Hz.
plus conventional therapy
will receive Conventional physical therapy in form of stretching exercise of posterior shoulder capsule, passive stretching exercise, will be done only 3 times with holding time 30 sec and 10 sec rest period between repetitions , strengthing exercise consists of 3 exercises all have been recommended as essential for any shoulder rehabilitation program.
These exercise include shoulder flexion, scaption and horizontal extension.
for each exercise, a 10-repetition maximum for 3 sets with 60 sec rest between every set + TENS and hot back.
|
|
Experimental: Extracorporeal Shock Wave
Twenty-three patients with chronic supraspinatus tendinopathy will receive extracorporeal shock wave and conventional physiotherapy twice a week for six weeks
|
will receive Conventional physical therapy in form of stretching exercise of posterior shoulder capsule, passive stretching exercise, will be done only 3 times with holding time 30 sec and 10 sec rest period between repetitions , strengthing exercise consists of 3 exercises all have been recommended as essential for any shoulder rehabilitation program.
These exercise include shoulder flexion, scaption and horizontal extension.
for each exercise, a 10-repetition maximum for 3 sets with 60 sec rest between every set + TENS and hot back.
patients will be sitting with shoulder abduction at 45 and elbow flexed and the forearm rested on flat surface and shock wave applicator directed in the most tender point near the insertion at the greater tubrosity under acromion with 2000 impulses, and energy flex density of 0.22mj/mm , pulse rate 10/sec and frequency 1-15 Hz plus conventional therapy
|
|
Comparador activo: conventional therapy
Twenty-three patients with chronic supraspinatus tendinopathy will receive conventional physiotherapy twice a week for six weeks
|
will receive Conventional physical therapy in form of stretching exercise of posterior shoulder capsule, passive stretching exercise, will be done only 3 times with holding time 30 sec and 10 sec rest period between repetitions , strengthing exercise consists of 3 exercises all have been recommended as essential for any shoulder rehabilitation program.
These exercise include shoulder flexion, scaption and horizontal extension.
for each exercise, a 10-repetition maximum for 3 sets with 60 sec rest between every set + TENS and hot back.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
supraspinatous tendon thickness
Periodo de tiempo: up to 6 weeks
|
supraspinatus tendon thickness will be assess by ultrasonography.The tendon often appears swollen or thickened (frequently > 6 to 7 mm)
|
up to 6 weeks
|
|
supracromial space
Periodo de tiempo: up to 6 weeks
|
supracromial space will be measured by ultrasonography.
A normal resting subacromial space generally ranges from 9 to 11 mm.
A measurement of less than 6 mm is often pathological
|
up to 6 weeks
|
|
occupation ratio of subacromial space
Periodo de tiempo: up to 6 weeks
|
The ratio comparing the thickness of the supraspinatus tendon to the overall acromiohumeral distance.
An increased occupation ratio (i.e., a thickened tendon taking up too much of the space) indicates a higher risk of impingement
|
up to 6 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
pain intensity
Periodo de tiempo: up to 6 weeks
|
visuala analogue scale will be used to assess pain intesity.
it is a line of 100 mm.The ends are labeled with extremes, such as "No pain" at 0 mm and "Worst pain imaginable" at 100 mm.
|
up to 6 weeks
|
|
shoulder range of motion
Periodo de tiempo: up to six weeks
|
the range of motion will be measured by electrogoniometer
|
up to six weeks
|
|
upper limb disability
Periodo de tiempo: up to six weeks
|
The QuickDASH will be used to assess upper limb function.the
QuickDASH is an 11-item questionnaire used to measure physical function and symptoms in people with upper limb disorders.
Scores range from 0 (no disability) to 100 (most severe disability).
|
up to six weeks
|
|
supraspinatus muscle strength
Periodo de tiempo: up to six weeks
|
supraspinatus muscle strength will be measured by handheld dynamometer
|
up to six weeks
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
30 de junio de 2026
Finalización primaria (Estimado)
25 de abril de 2027
Finalización del estudio (Estimado)
25 de abril de 2027
Fechas de registro del estudio
Enviado por primera vez
19 de junio de 2026
Primero enviado que cumplió con los criterios de control de calidad
19 de junio de 2026
Publicado por primera vez (Actual)
25 de junio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
25 de junio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
19 de junio de 2026
Última verificación
1 de junio de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- P.T.REC/012/006491
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .